The role of PSMA-based radioligand therapy in hormone-sensitive prostate cancer.

Laudicella R, Bauckneht M, Burger IA, Cacciola A, Fanti S, Farolfi A, Ficarra V, Iagaru A, Liberini V, Pergolizzi S, Santo G, Virgolini I, Minutoli F, Baldari S

Open source

DOI: 10.1007/s00259-025-07083-8
Published: 2025 Jun
Container: European journal of nuclear medicine and molecular imaging
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00259-025-07083-8,
  title = {The role of PSMA-based radioligand therapy in hormone-sensitive prostate cancer.},
  author = {Laudicella R and Bauckneht M and Burger IA and Cacciola A and Fanti S and Farolfi A and Ficarra V and Iagaru A and Liberini V and Pergolizzi S and Santo G and Virgolini I and Minutoli F and Baldari S},
  year = {2025},
  journal = {European journal of nuclear medicine and molecular imaging},
  doi = {10.1007/s00259-025-07083-8},
  url = {https://doi.org/10.1007/s00259-025-07083-8}
}

RIS

TY  - JOUR
TI  - The role of PSMA-based radioligand therapy in hormone-sensitive prostate cancer.
AU  - Laudicella R
AU  - Bauckneht M
AU  - Burger IA
AU  - Cacciola A
AU  - Fanti S
AU  - Farolfi A
AU  - Ficarra V
AU  - Iagaru A
AU  - Liberini V
AU  - Pergolizzi S
AU  - Santo G
AU  - Virgolini I
AU  - Minutoli F
AU  - Baldari S
PY  - 2025
JO  - European journal of nuclear medicine and molecular imaging
DO  - 10.1007/s00259-025-07083-8
UR  - https://doi.org/10.1007/s00259-025-07083-8
ER  -

APA

R, L., M, B., IA, B., A, C., S, F., A, F., V, F., A, I., V, L., S, P., G, S., I, V., F, M., & S, B. (2025). The role of PSMA-based radioligand therapy in hormone-sensitive prostate cancer.. European journal of nuclear medicine and molecular imaging. https://doi.org/10.1007/s00259-025-07083-8

Source records

pubmed · retrieved 2026-09-25T08:12:42.235Z